The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO 2024 | The role of sex and gender in colorectal cancer treatment
Kathrin Heinrich, MD, Ludwig-Maximilians-Universität München, Munich, Germany, emphasizes the significance impact of sex and gender on colorectal cancer management. While sex refers to biological differences, gender encompasses the social and cultural influences on disease development and treatment. These factors affect diagnostic accuracy, treatment efficacy, and side effect profiles. For example, female patients have a higher risk of severe adverse events with 5-fluorouracil treatment. Understanding how gender influences treatment response is critical for optimizing colorectal cancer care. This interview took place at the European Society for Medical Oncology (ESMO) 2024 Congress in Barcelona, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
